Company news

Collegium Pharmaceutical, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Collegium Announces Settlement Framework to Resolve Pending Opioid-Related Litigation

December 27, 2021

Collegium Ranks as a Top Place to Work for 2021 by The Boston Globe

December 5, 2021

UPDATE: Collegium to Participate in Upcoming Conferences

November 10, 2021

Collegium Reports Third Quarter Fiscal 2021 Results

November 3, 2021

Collegium to Host Conference Call to Discuss Third Quarter 2021 Financial Results and Provide Corporate Update

October 20, 2021

Collegium Announces Four Posters Presented at PAINWeek 2021 National Conference

September 12, 2021

Collegium Announces $100 Million Share Repurchase Program

August 15, 2021

Collegium Reports Strong Q2 Results with Cash Balance Growing to Over $200 Million

August 4, 2021

Collegium to Host Conference Call to Discuss Second Quarter 2021 Financial Results and Provide Corporate Update

July 20, 2021

Collegium Announces Publication of Real-World Data in Journal of Pain Research

June 15, 2021

Collegium to Participate in Upcoming Investor Conference

May 19, 2021

Collegium Reports Record Quarterly Revenue of $87.7 Million

May 5, 2021

Collegium to Host Conference Call to Discuss First Quarter 2021 Financial Results and Provide Corporate Update

April 14, 2021

Collegium Reports Record Full-Year 2020 Revenue of $310.0 Million

February 24, 2021

Collegium to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and Provide Corporate Update

February 10, 2021

Collegium Provides 2021 Financial Guidance

January 5, 2021

Collegium Reports Net Income of $11.3 Million in the Third Quarter of 2020

November 4, 2020

Collegium Announces Publication of “Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza® ER” in Pain Medicine

October 25, 2020

Collegium to Host Conference Call to Discuss Third Quarter 2020 Financial Results and Provide Corporate Update

October 21, 2020

Collegium Announces Settlement with Teva Resolving Xtampza® ER Patent Litigation

September 29, 2020

Collegium Appoints Rita Balice-Gordon to its Board of Directors

September 24, 2020

Collegium Announces Five Posters Presented at PAINWeek 2020 National Conference

September 13, 2020

Collegium Announces Scientific Presentations at PAINWeek 2020 National Conference

September 8, 2020

Collegium Reports Net Income of $8.1 Million in the Second Quarter of 2020

August 4, 2020

Collegium to Host Conference Call to Discuss Second Quarter 2020 Financial Results and Provide Corporate Update

July 20, 2020

Collegium Pharmaceutical Named one of Boston Business Journal’s 2020 Best Places to Work

June 16, 2020

Collegium Reports First Quarter 2020 Profitability

May 6, 2020

Collegium to Host Conference Call to Discuss First Quarter 2020 Financial Results and Provide Corporate Update

April 22, 2020

Collegium Reports Full-Year 2019 Revenue of $296.7 Million

February 26, 2020

Collegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Provide Corporate Update

February 25, 2020

Collegium Announces Closing of the Nucynta Franchise Acquisition

February 12, 2020

Collegium Pharmaceutical, Inc. Prices $125.0 Million Convertible Senior Notes Offering

February 9, 2020

Collegium to Acquire U.S. Rights to Nucynta Franchise

February 5, 2020

Collegium Provides 2020 Financial Guidance

January 6, 2020

Collegium Reports Third Quarter 2019 Financial Results

November 5, 2019

Collegium to Host Conference Call to Discuss Third Quarter 2019 Financial Results and Provide Corporate Update

October 22, 2019

← Newer news releases

Calls

The 5 newest of 31 calls. Every call is listed under its year.

Decks

The 5 newest of 36 decks. Every deck is listed under its year.